India's Pharmaceutical Exports

Country Profile

Netherlands

Netherlands is a major destination for Indian pharmaceutical exports — $749M in FY 2025–26, with 3.2× growth over the past decade. Medicines accounts for 66% of shipments, with vaccines contributing $5.06M. The compound annual growth rate since FY2016 stands at 12.3%.

🇳🇱 #9 Destination · $749M · 3.2× growth since FY2016
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$749M
Exports FY2025–26 DGCIS
3.2×
Growth FY2016→2026
2.4%
Share of India Total
#9
Rank Among 178 Markets
12.3%
CAGR FY2016→2026
Netherlands is a major destination for Indian pharmaceutical exports — $749M in FY 2025–26, with 3.2× growth over the past decade. Medicines accounts for 66% of shipments, with vaccines contributing $5.06M. The compound annual growth rate since FY2016 stands at 12.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $497M (66.3%) Medicine Ingredients $210M (28.0%) Surgical & Hospital Supplies $25.6M (3.4%) Traditional & Herbal $11.6M (1.5%) Vaccines $5.06M (0.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Netherlands in the RBI overseas direct investment dataset (2011–2026).